Are liver metastases from uveal melanoma a clinical indication for dynamic PET? A comparison of Patlak parametric imaging with standard and delayed static SUV imaging using long axial field-of-view PET/CT
European Journal of Nuclear Medicine and Molecular Imaging · 2026
DOI: 10.1007/s00259-026-08014-x ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, 2026. Verfasst von Leyun Pan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69210, Heidelberg, Germany. l.pan@dkfz-hei…. Hauptthemen laut MEDLINE: Melanoma, Uveal Neoplasms, Positron Emission Tomography Computed Tomography, Liver Neoplasms. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsches Krebsforschungszentrum (DKFZ).
Abstract (Originalsprache)
Purpose
Despite decades of technical development, dynamic PET and parametric imaging have not yet achieved widespread clinical implementation in oncology, largely due to technical complexity and the limited number of clinical scenarios in which clear additional value over static imaging has been demonstrated. We hypothesized that liver metastases from uveal melanoma—a tumor entity often characterized by low tumor-to-background contrast on static imaging— may represent a particularly promising application for dynamic PET imaging. Accordingly, we aimed to determine whether dynamic Patlak parametric imaging improves lesion detectability and conspicuity compared with standard (50–60 min) and delayed (70–85 min) static standardized uptake value (SUV) imaging. Material and methods Twenty-six patients with uveal melanoma and a total of 126 tumor lesions, including 58 liver metastases and 68 other metastases, were prospectively enrolled. All patients underwent a 60 min dynamic data acquisition (skull to upper thigh) followed by whole-body [ 18 F]FDG PET/CT imaging at 70 min post-injection. Three image datasets were generated and compared: (1) Direct Patlak K i parametric images derived from dynamic acquisition at 30–60 min post-injection, (2) standard static SUV images reconstructed from same dynamic acquisition at 50–60 min post-injection (standardSUV), and (3) delayed static SUV images acquired at 70–85 min post-injection (lateSUV). All three image sets were assessed qualitatively for lesion detectability and quantitative analysis was performed for all 126 lesions using tumor-to-background ratio (TBR mean ) measurements.
Results
No significant differences were observed among the three imaging approaches with respect to the total number of detected tumor lesions. However, one discordant finding was noted: a true-positive liver metastasis was identified on Patlak K i imaging and subsequently confirmed by MRI, but was not clearly visualized on static SUV images. Qualitatively, for liver and other metastases, Patlak K i and lateSUV images showed significantly higher TBR mean values than standardSUV, with mean increases of ~ 2.1–2.3-fold for K i and ~ 1.3-fold for lateSUV. Furthermore, Patlak K i yielded significantly higher TBR mean than lateSUV (52/58 and 65/68) and standardSUV (57/58 and 67/68) for liver and other metastases, respectively.
Conclusions
Although lesion detection rates were not significantly increased, dynamic acquisition with Patlak parametric imaging provided a robust and less timing-dependent method to enhance tumor-to-background contrast compared with static SUV imaging and may yield discordant findings with additional clinical value in selected cases. Overall, Patlak imaging may therefore represent a complementary contrast-optimization approach for evaluating liver metastases from uveal melanoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69210, Heidelberg, Germany. l.pan@dkfz-heidelberg.de.
- Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69210, Heidelberg, Germany.
- Department of Radiology, University Hospital Heidelberg, Heidelberg, Germany.
- Heidelberg University, Medical Faculty Heidelberg, Department of Dermatology and National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and University Hospital Heidelberg, Heidelberg, Germa…
ORCID-Profile: Leyun Pan
Förderung
- Deutsches Krebsforschungszentrum (DKFZ)
Zitieren
APA
Pan, L., Sachpekidis, C., Strauss, D. S., Hassel, J. C., & Dimitrakopoulou-Strauss, A. (2026). Are liver metastases from uveal melanoma a clinical indication for dynamic PET? A comparison of Patlak parametric imaging with standard and delayed static SUV imaging using long axial field-of-view PET/CT. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-026-08014-x
Vancouver
Pan L, Sachpekidis C, Strauss DS, Hassel JC, Dimitrakopoulou-Strauss A. Are liver metastases from uveal melanoma a clinical indication for dynamic PET? A comparison of Patlak parametric imaging with standard and delayed static SUV imaging using long axial field-of-view PET/CT. European Journal of Nuclear Medicine and Molecular Imaging. 2026. doi:10.1007/s00259-026-08014-x
BibTeX
@article{Pan2026,
author = {Pan, Leyun and Sachpekidis, Christos and Strauss, Dimitrios S and Hassel, Jessica C and Dimitrakopoulou-Strauss, Antonia},
title = {Are liver metastases from uveal melanoma a clinical indication for dynamic PET? A comparison of Patlak parametric imaging with standard and delayed static SUV imaging using long axial field-of-view PET/CT},
journal = {European Journal of Nuclear Medicine and Molecular Imaging},
year = {2026},
doi = {10.1007/s00259-026-08014-x}
}
EUVIMED